<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01278875</url>
  </required_header>
  <id_info>
    <org_study_id>10-208-BMA</org_study_id>
    <nct_id>NCT01278875</nct_id>
  </id_info>
  <brief_title>Function of High Density Lipoproteins in Acute Coronary Syndromes</brief_title>
  <acronym>HDL_ACS</acronym>
  <official_title>High Density Lipoprotein Function in Acute Coronary Syndromes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McGill University Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High density lipoproteins (HDL) have many effects that protect against cardiovascular
      diseases. In an acute heart attack (acute coronary syndrome -ACS), HDL change in composition
      and structure, reflecting the inflammatory environment that accompanies an ACS. The
      investigators will examine the function of HDL during an ACS and again when the patient has
      recovered.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High density lipoproteins (HDL) have pleiotropic effects associated with protection against
      atherosclerosis. These effects include cellular cholesterol efflux, anti-inflammatory and
      anti-oxidant effects, increase in nitric acid (NO) production from vascular endothelial cells
      and differentiation of endothelial progenitor cells for repair at sites of vascular injury.
      The measurement of the cholesterol mass within HDL (HDL-C) does not provide an adequate
      measure of HDL function. The investigators therefore propose to test and validate biomarkers
      of HDL function in patients with acute coronary syndromes (ACS).

      Hypothesis: HDL lose their cardiovascular protective functions in ACS. The investigators
      hypothesize that these changes are transient and partly normalize within 12 weeks. In this
      proposal, the investigators will examine the function of HDL in acute coronary syndromes
      (ACS) and 12 weeks later, in the recovery phase. Acute coronary syndromes are characterized
      by an acute inflammatory reaction, a marked decrease in HDL in plasma and a shift of the HDL
      proteome to an inflammatory phenotype.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HDL-mediated cellular cholesterol efflux</measure>
    <time_frame>12 weeks</time_frame>
    <description>Biomarkers of HDL function</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Acute Coronary Syndrome</arm_group_label>
    <description>Subjects with ACS within 72 hours of clinical presentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stable CAD subjects</arm_group_label>
    <description>Patients with stable, chronic CAD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <description>Healthy individuals</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum Plasma HDL isolated by ultracentrifugation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to hospital with an acute coronary syndrome, within 72 hours
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women 18-80 years of age

          -  Acute Coronary Syndrome within 72 hours of presentation

          -  Elevated tropinins (T or I)

        Exclusion Criteria:

          -  Refusal to participate

          -  Inability to return for a 12 week follow-up visit

          -  Hemodynamic instability requiring vasopressor support, mechanical ventricular assist
             devices, the need for coronary artery bypass surgery

          -  Lack of documented atherosclerotic CAD

          -  Uncontrolled hypertension

          -  Triglycerides≥5mmol/L

          -  Severe obesity (BMI≥35)

          -  Alcohol intake&gt;21 drinks/week

          -  Presence of thyroid, hepatic, or renal disease

          -  Autoimmune disease or any chronic or acute infectious or inflammatory illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Genest, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jacques Genest, MD</last_name>
    <phone>514 934-1934</phone>
    <phone_ext>34630</phone_ext>
    <email>jacques.genest@muhc.mcgill.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Colette Rondeau, RN</last_name>
    <phone>514 934-1934</phone>
    <phone_ext>36576</phone_ext>
    <email>colette.rondeau@muhc.mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jacques Genest, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc Bilodeau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2011</study_first_submitted>
  <study_first_submitted_qc>January 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2011</study_first_posted>
  <last_update_submitted>June 20, 2014</last_update_submitted>
  <last_update_submitted_qc>June 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Center</investigator_affiliation>
    <investigator_full_name>Jacques Genest</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>High density lipoproteins</keyword>
  <keyword>Acute coronary syndromes</keyword>
  <keyword>Cellular cholesterol efflux</keyword>
  <keyword>HDL: proteomics</keyword>
  <keyword>Nitric Acid production</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

